E. coli

Antibiotic
% Susceptible
2010
% Susceptible
2012
% Susceptible
2014
% Susceptible
2016
% Susceptible
2018
Ampicillin
61
63 65 65 66
Azithromycin
-
-
-
- -
Aztreonam
99
98
98
98 98
Cefazolin
91
92
93
93 92
Cefepime
98
98
98
98 97
Ceftazidime
98
98
98
97 97
Ceftriaxone
98
93
94
97 96
Cefuroxime
95
95
96
95 94
Ciprofloxacin
85
86
90
89 89
Clarithromycin
-
-
-
- -
Clindamycin
-
-
-
- -
Doxycycline
79
82
83
+ +
Erythromycin
-
-
-
- -
Gentamicin
93
94
95
95 95
Imipenem
100
100
100
100 100
Levofloxacin 86 87 90 89 89
Meropenem + 100 100 100 100
Moxifloxacin + + + + +
Nitrofurantoin 96& 98& 99& 99& 99&
Oxacillin/Naf - - - - -
Penicillin - - - - -
Piperacillin 63 65 66 + +
Piperacillin/tazo 98 99 99 99 99
Ticarcillin/Clav + + + + +
Tobramycin 93 94 95 95 95
TMP/SMX 79 80 83 83 84
Unasyn/Aug 64 64 69 70 69
Vancomycin - - - - -
       
# Tested 5809 7262 6044 6129 6426

Comments:   Though commonly used to treat UTI's, there is some resistance to TMP/SMX and fluoroquinolones

 

Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections